Why It Matters

The Pharmaceutical Care Management Association (PCMA) added Indigo Hill Strategies to its roster in a new client registration signed Nov. 6. The filing lists Health Issues (HCR) and the specific issue "Pharmacy benefit Manager (PBM) issues," so PCMA lobbying on pharmacy benefit managers now has another firm behind it. ​

PCMA already lobbies in-house and through other firms. Its third-quarter reports came from in-house staff and from Emergent Strategies LLC, Red+Blue Strategies, Fierce Government Relations, Continental Strategy LLC, Ryan Costello Strategies LLC and Gibson Group LLC. Gazitua Letelier PA signed a new client registration on Sept. 2, in the third quarter. Forward Global US Inc. filed a third-quarter termination, with a termination date of July 1.

By the Numbers

The registration carries a $0 filing amount and lists no bills. PCMA's in-house third-quarter report shows $3,203,049, its in-house second-quarter report $3,282,990, and its in-house first-quarter amendment $2,996,995.

The registration lists one lobbyist, Ryann Hill, with the covered position "Founder/CEO."

Broader Context

The Department of Labor (DOL) finalized a rule on Oct. 29 requiring PBMs and affiliated brokers and consultants to disclose fees and compensation to large employers' self-insured health plans, according to DOL. DOL says the rule implements transparency reforms in the Consolidated Appropriations Act 2026, and projects up to $22 billion in savings over 10 years.

PCMA said the same day that the rule duplicates reporting requirements in the new federal PBM law and could increase costs and reduce competition, particularly for smaller PBMs.

Advertisement

Competitive Landscape

Immix Biopharma Inc. hired Brownstein Hyatt Farber Schreck LLP on Nov. 4 to lobby on pharmacy and health issues (HCR). Unicycive Therapeutics Inc. hired KPM Group DC LLC on Nov. 6 on health issues (HCR). Insulet Corp. hired ML Strategies LLC on Nov. 3 on health issues (HCR).

The Bottom Line

The registration gives PCMA another outside firm on pharmacy benefit manager issues. With no bills named, the filing itself points only to the issue area and the PBM topic.

Access the Legis1 platform for comprehensive political news, data, and insights.

Spot something wrong? Report an issue with this article